Upregulation of FTX inhibits the conversion of NAFLD to HCC by promoting M1 polarization of KC and provokes another effective target for the treatment of NAFLD-HCC (27). This evidence concerns the gene CALCA and metabolic dysfunction-associated steatotic liver disease.